21 October 2016
: Case report
Inadvertent Methylergonovine Administration to a Neonate
Diagnostic / therapeutic accidents, Management of emergency care, Clinical situation which can not be reproduced for ethical reasons
Bryan M. CorbettEF, Charles O'ConnellEF, Mallory A. BoutinEF, Nabil I. FatayerjiEF, Charles W. SauerEFDOI: 10.12659/AJCR.900263
Am J Case Rep 2016; 17:770-773
Abstract
BACKGROUND: Methylergonovine is an ergot alkaloid used to treat post-partum hemorrhage secondary to uterine atony. Mistaking methylergonovine for vitamin K with accidental administration to the neonate is a rare iatrogenic illness occurring almost exclusively in the delivery room setting. Complications of ergot alkaloids in neonates include respiratory depression, seizures, and death.
CASE REPORT: A term infant was inadvertently given 0.1 mg of methylergonovine intramuscularly in the right thigh. The error was only noted when the vial of medication was scanned, after administration, identifying it as methylergonovine rather than vitamin K. The local poison center was notified, and the infant was transferred to the neonatal intensive care unit for observation. Two hours after transfer, the infant was noted to have oxygen desaturations and required oxygen via nasal cannula. Supplemental oxygen was continued for 4 hours until the neonate was able to maintain normal oxygen saturations in room air. Feeding was started by 10 hours of life, and the infant was discharged home in good condition after a 72-hour stay without further complications.
CONCLUSIONS: Because of the potential for serious adverse events, vigilance is required to prevent accidental administration of methylergonovine to the neonate as a result of possible confusion with vitamin K in the early post-partum period.
Keywords: Infant, Newborn, Intensive Care, Neonatal, Methylergonovine, Poisoning, Vitamin K
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947693
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947911
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946435
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947160
Most Viewed Current Articles
21 Jun 2024 : Case report
100,331
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
53,693
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
36,172
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
07 Jul 2023 : Case report
24,938
DOI :10.12659/AJCR.940200
Am J Case Rep 2023; 24:e940200